Global Cancer Immunotherapy Market Research Report Forecast 2017-2021 Chapter 1 Cancer Immunotherapy Market Overview 1.1 Product Overview and Scope of Cancer Immunotherapy 1.2 Cancer Immunotherapy Market Segmentation by Type 1.2.1 Global Production Market Share of Cancer Immunotherapy by Type in 2015 1.2.1 Type 1 1.2.2 Type 2 1.2.3 Type 3 1.3 Cancer Immunotherapy Market Segmentation by Application 1.3.1 Cancer Immunotherapy Consumption Market Share by Application in 2015 1.3.2 Application 1 1.3.3 Application 2 1.3.4 Application 3 1.4 Cancer Immunotherapy Market Segmentation by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 1.5 Global Market Size (Value) of Cancer Immunotherapy (2012-2021) Chapter 2 Global Economic Impact on Cancer Immunotherapy Industry 2.1 Global Macroeconomic Environment Analysis 2.1.1 Global Macroeconomic Analysis 2.1.2 Global Macroeconomic Environment Development Trend 2.2 Global Macroeconomic Environment Analysis by Regions Chapter 3 Global Cancer Immunotherapy Market Competition by Manufacturers 3.1 Global Cancer Immunotherapy Production and Share by Manufacturers (2015 and 2016) 3.2 Global Cancer Immunotherapy Revenue and Share by Manufacturers (2015 and 2016) 3.3 Global Cancer Immunotherapy Average Price by Manufacturers (2015 and 2016) 3.4 Manufacturers Cancer Immunotherapy Manufacturing Base Distribution, Production Area and Product Type 3.5 Cancer Immunotherapy Market Competitive Situation and Trends 3.5.1 Cancer Immunotherapy Market Concentration Rate 3.5.2 Cancer Immunotherapy Market Share of Top 3 and Top 5 Manufacturers 3.5.3 Mergers & Acquisitions, Expansion Chapter 4 Global Cancer Immunotherapy Production, Revenue (Value) by Region (2012-2017) 4.1 Global Cancer Immunotherapy Production by Region (2012-2017) 4.2 Global Cancer Immunotherapy Production Market Share by Region (2012-2017) 4.3 Global Cancer Immunotherapy Revenue (Value) and Market Share by Region (2012-2017) 4.4 Global Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) 4.5 North America Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) 4.6 Europe Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) 4.7 China Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) 4.8 Japan Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) 4.9 Southeast Asia Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) 4.10 India Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Chapter 5 Global Cancer Immunotherapy Supply (Production), Consumption, Export, Import by Regions (2012-2017) 5.1 Global Cancer Immunotherapy Consumption by Regions (2012-2017) 5.2 North America Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017) 5.3 Europe Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017) 5.4 China Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017) 5.5 Japan Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017) 5.6 Southeast Asia Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017) 5.7 India Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017) Chapter 6 Global Cancer Immunotherapy Production, Revenue (Value), Price Trend by Type 6.1 Global Cancer Immunotherapy Production and Market Share by Type (2012-2017) 6.2 Global Cancer Immunotherapy Revenue and Market Share by Type (2012-2017) 6.3 Global Cancer Immunotherapy Price by Type (2012-2017) 6.4 Global Cancer Immunotherapy Production Growth by Type (2012-2017) Chapter 7 Global Cancer Immunotherapy Market Analysis by Application 7.1 Global Cancer Immunotherapy Consumption and Market Share by Application (2012-2017) 7.2 Global Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017) 7.3 Market Drivers and Opportunities 7.3.1 Potential Applications 7.3.2 Emerging Markets/Countries Chapter 8 Global Cancer Immunotherapy Manufacturers Analysis 8.1 Amgen 8.1.1 Company Basic Information, Manufacturing Base and Competitors 8.1.2 Product Type, Application and Specification 8.1.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.1.4 Business Overview 8.2 AstraZeneca 8.2.1 Company Basic Information, Manufacturing Base and Competitors 8.2.2 Product Type, Application and Specification 8.2.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.2.4 Business Overview 8.3 F. Hoffman La-Roche 8.3.1 Company Basic Information, Manufacturing Base and Competitors 8.3.2 Product Type, Application and Specification 8.3.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.3.4 Business Overview 8.4 Bayer AG 8.4.1 Company Basic Information, Manufacturing Base and Competitors 8.4.2 Product Type, Application and Specification 8.4.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.4.4 Business Overview 8.5 Bristol-Myers Squibb 8.5.1 Company Basic Information, Manufacturing Base and Competitors 8.5.2 Product Type, Application and Specification 8.5.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.5.4 Business Overview 8.6 Eli Lilly and Company 8.6.1 Company Basic Information, Manufacturing Base and Competitors 8.6.2 Product Type, Application and Specification 8.6.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.6.4 Business Overview 8.7 Janssen Global Services 8.7.1 Company Basic Information, Manufacturing Base and Competitors 8.7.2 Product Type, Application and Specification 8.7.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.7.4 Business Overview 8.8 Merck 8.8.1 Company Basic Information, Manufacturing Base and Competitors 8.8.2 Product Type, Application and Specification 8.8.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.8.4 Business Overview 8.9 Novartis 8.9.1 Company Basic Information, Manufacturing Base and Competitors 8.9.2 Product Type, Application and Specification 8.9.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.9.4 Business Overview … Chapter 9 Cancer Immunotherapy Manufacturing Cost Analysis 9.1 Cancer Immunotherapy Key Raw Materials Analysis 9.1.1 Key Raw Materials 9.1.2 Price Trend of Key Raw Materials 9.1.3 Key Suppliers of Raw Materials 9.1.4 Market Concentration Rate of Raw Materials 9.2 Proportion of Manufacturing Cost Structure 9.2.1 Raw Materials 9.2.2 Labor Cost 9.2.3 Manufacturing Expenses 9.3 Manufacturing Process Analysis of Cancer Immunotherapy Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers 10.1 Cancer Immunotherapy Industrial Chain Analysis 10.2 Upstream Raw Materials Sourcing 10.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015 10.4 Downstream Buyers Chapter 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Marketing Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List Chapter 12 Market Effect Factors Analysis 12.1 Technology Progress/Risk 12.1.1 Substitutes Threat 12.1.2 Technology Progress in Related Industry 12.2 Consumer Needs/Customer Preference Change 12.3 Economic/Political Environmental Change Chapter 13 Global Cancer Immunotherapy Market Forecast (2017-2021) 13.1 Global Cancer Immunotherapy Production, Revenue Forecast (2017-2021) 13.2 Global Cancer Immunotherapy Production, Consumption Forecast by Regions (2017-2021) 13.3 Global Cancer Immunotherapy Production Forecast by Type (2017-2021) 13.4 Global Cancer Immunotherapy Consumption Forecast by Application (2017-2021) 13.5 Cancer Immunotherapy Price Forecast (2017-2021) Chapter 14 Appendix

Figure Picture of Cancer Immunotherapy Figure Global Production Market Share of Cancer Immunotherapy by Type in 2015 Figure Product Picture of Type I Table Major Manufacturers of Type I Figure Product Picture of Type II Table Major Manufacturers of Type II Figure Product Picture of Type III Table Major Manufacturers of Type III Table Cancer Immunotherapy Consumption Market Share by Application in 2015 Figure Application 1 Examples Figure Application 2 Examples Figure Application 3 Examples Figure North America Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021) Figure Europe Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021) Figure China Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021) Figure Japan Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021) Figure Southeast Asia Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021) Figure India Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021) Figure Global Cancer Immunotherapy Revenue (Million UDS) and Growth Rate (2012-2021) Table Global Cancer Immunotherapy Capacity of Key Manufacturers (2015 and 2016) Table Global Cancer Immunotherapy Capacity Market Share by Manufacturers (2015 and 2016) Figure Global Cancer Immunotherapy Capacity of Key Manufacturers in 2015 Figure Global Cancer Immunotherapy Capacity of Key Manufacturers in 2016 Table Global Cancer Immunotherapy Production of Key Manufacturers (2015 and 2016) Table Global Cancer Immunotherapy Production Share by Manufacturers (2015 and 2016) Figure 2015 Cancer Immunotherapy Production Share by Manufacturers Figure 2016 Cancer Immunotherapy Production Share by Manufacturers Table Global Cancer Immunotherapy Revenue (Million USD) by Manufacturers (2015 and 2016) Table Global Cancer Immunotherapy Revenue Share by Manufacturers (2015 and 2016) Table 2015 Global Cancer Immunotherapy Revenue Share by Manufacturers Table 2016 Global Cancer Immunotherapy Revenue Share by Manufacturers Table Global Market Cancer Immunotherapy Average Price of Key Manufacturers (2015 and 2016) Figure Global Market Cancer Immunotherapy Average Price of Key Manufacturers in 2015 Table Manufacturers Cancer Immunotherapy Manufacturing Base Distribution and Sales Area Table Manufacturers Cancer Immunotherapy Product Type Figure Cancer Immunotherapy Market Share of Top 3 Manufacturers Figure Cancer Immunotherapy Market Share of Top 5 Manufacturers Table Global Cancer Immunotherapy Capacity by Regions (2012-2017) Figure Global Cancer Immunotherapy Capacity Market Share by Regions (2012-2017) Figure Global Cancer Immunotherapy Capacity Market Share by Regions (2012-2017) Figure 2015 Global Cancer Immunotherapy Capacity Market Share by Regions Table Global Cancer Immunotherapy Production by Regions (2012-2017) Figure Global Cancer Immunotherapy Production and Market Share by Regions (2012-2017) Figure Global Cancer Immunotherapy Production Market Share by Regions (2012-2017) Figure 2015 Global Cancer Immunotherapy Production Market Share by Regions Table Global Cancer Immunotherapy Revenue by Regions (2012-2017) Table Global Cancer Immunotherapy Revenue Market Share by Regions (2012-2017) Table 2015 Global Cancer Immunotherapy Revenue Market Share by Regions Table Global Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table North America Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Europe Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table China Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Japan Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Southeast Asia Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table India Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Global Cancer Immunotherapy Consumption Market by Regions (2012-2017) Table Global Cancer Immunotherapy Consumption Market Share by Regions (2012-2017) Figure Global Cancer Immunotherapy Consumption Market Share by Regions (2012-2017) Figure 2015 Global Cancer Immunotherapy Consumption Market Share by Regions Table North America Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017) Table Europe Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017) Table China Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017) Table Japan Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017) Table Southeast Asia Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017) Table India Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017) Table Global Cancer Immunotherapy Production by Type (2012-2017) Table Global Cancer Immunotherapy Production Share by Type (2012-2017) Figure Production Market Share of Cancer Immunotherapy by Type (2012-2017) Figure 2015 Production Market Share of Cancer Immunotherapy by Type Table Global Cancer Immunotherapy Revenue by Type (2012-2017) Table Global Cancer Immunotherapy Revenue Share by Type (2012-2017) Figure Production Revenue Share of Cancer Immunotherapy by Type (2012-2017) Figure 2015 Revenue Market Share of Cancer Immunotherapy by Type Table Global Cancer Immunotherapy Price by Type (2012-2017) Figure Global Cancer Immunotherapy Production Growth by Type (2012-2017) Table Global Cancer Immunotherapy Consumption by Application (2012-2017) Table Global Cancer Immunotherapy Consumption Market Share by Application (2012-2017) Figure Global Cancer Immunotherapy Consumption Market Share by Application in 2015 Table Global Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017) Figure Global Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017) Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors Table Amgen Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Amgen Cancer Immunotherapy Market Share (2012-2017) Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors Table AstraZeneca Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table AstraZeneca Cancer Immunotherapy Market Share (2012-2017) Table F. Hoffman La-Roche Basic Information, Manufacturing Base, Production Area and Its Competitors Table F. Hoffman La-Roche Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table F. Hoffman La-Roche Cancer Immunotherapy Market Share (2012-2017) Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors Table Bayer AG Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Bayer AG Cancer Immunotherapy Market Share (2012-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors Table Bristol-Myers Squibb Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Bristol-Myers Squibb Cancer Immunotherapy Market Share (2012-2017) Table Eli Lilly and Company Basic Information, Manufacturing Base, Production Area and Its Competitors Table Eli Lilly and Company Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Eli Lilly and Company Cancer Immunotherapy Market Share (2012-2017) Table Janssen Global Services Basic Information, Manufacturing Base, Production Area and Its Competitors Table Janssen Global Services Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Janssen Global Services Cancer Immunotherapy Market Share (2012-2017) Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors Table Merck Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Merck Cancer Immunotherapy Market Share (2012-2017) Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors Table Novartis Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017) Table Novartis Cancer Immunotherapy Market Share (2012-2017) … Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Cancer Immunotherapy Figure Manufacturing Process Analysis of Cancer Immunotherapy Figure Cancer Immunotherapy Industrial Chain Analysis Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015 Table Major Buyers of Cancer Immunotherapy Table Distributors/Traders List Figure Global Cancer Immunotherapy Production and Growth Rate Forecast (2017-2021) Figure Global Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021) Table Global Cancer Immunotherapy Production Forecast by Regions (2017-2021) Table Global Cancer Immunotherapy Consumption Forecast by Regions (2017-2021) Table Global Cancer Immunotherapy Production Forecast by Type (2017-2021) Table Global Cancer Immunotherapy Consumption Forecast by Application (2017-2021)